Renal angiomyolipoma (AML), a rare benign mesenchymal neoplasm, is characterized by the presence of vessels, smooth muscle, and adipose tissue. Treatment should be considered for symptomatic patients or for those at risk for complications, in particular for retroperitoneal bleeding, which is correlated to the size of the tumor, grade of the angiogenic component, and presence of tuberous sclerosis complex. Herein, we report the case of a 39-year-old female with renal AML who was treated in a conservative approach by super-selective embolization.

Keywords:
Angiomyolipoma, Embolization, Haemorrhage, Renal function, Selective angiography
1.
Hajdu SI, Foote FW Jr: Angiomyolipoma of the kidney: report of 27 cases and review of the literature. J Urol 1969; 102: 396–401.
2.
Koo KC, Kim WT, Ham WS, et al: Trends of presentation and clinical outcome of treated renal angiomyolipoma. Yonsei Med J 2010; 51: 728–734.
3.
Vekeman F, Magestro M, Karner P, et al: Kidney involvement in tuberous sclerosis complex: the impact on healthcare resource use and costs. J Med Econ 2015; 18: 1060–1070.
4.
Dickinson M, Ruckle H, Beaghler M, et alL Renal angiomyolipoma: optimal treatment based on size and symptoms. Clin Nephrol 1998; 49: 281–286.
5.
Ramon J, Rimon U, Garniek A, et al: Renal angiomyolipoma: long-term results following selective arterial embolization. Eur Urol 2009; 55: 1155–1161.
6.
Adler J, Greweldinger J, Litzky G: “Macro” aneurysm in renal angiomyolipoma: two cases, with therapeutic embolization in one patient. Urol Radiol 1984; 6: 201–203.
7.
Chick CM, Tan BS, Cheng C, et al: Long-term follow-up of the treatment of renal angiomyolipomas after selective arterial embolization with alcohol. BJU Int 2010; 105: 390–394.
8.
Faddegon S, So A: Treatment of angiomyolipoma at a tertiary care centre: the decision between surgery and angioembolization. Can Urol Assoc J 2011; 5:E138–E141.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.